McAdam LLC’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271K | Buy |
3,273
+159
| +5% | +$13.2K | 0.01% | 307 |
|
|
2025
Q1 | $253K | Sell |
3,114
-3,288
| -51% | -$267K | 0.02% | 285 |
|
|
2024
Q4 | $577K | Sell |
6,402
-1,248
| -16% | -$112K | 0.03% | 182 |
|
|
2024
Q3 | $756K | Sell |
7,650
-413
| -5% | -$40.8K | 0.04% | 154 |
|
|
2024
Q2 | $748K | Sell |
8,063
-3,105
| -28% | -$288K | 0.05% | 145 |
|
|
2024
Q1 | $1.06M | Buy |
11,168
+2,956
| +36% | +$280K | 0.07% | 113 |
|
|
2023
Q4 | $733K | Buy |
8,212
+295
| +4% | +$26.3K | 0.05% | 130 |
|
|
2023
Q3 | $578K | Sell |
7,917
-252
| -3% | -$18.4K | 0.05% | 145 |
|
|
2023
Q2 | $680K | Buy |
8,169
+34
| +0.4% | +$2.83K | 0.06% | 133 |
|
|
2023
Q1 | $620K | Sell |
8,135
-1,385
| -15% | -$106K | 0.06% | 136 |
|
|
2022
Q4 | $1.07M | Buy |
9,520
+654
| +7% | +$73.2K | 0.11% | 74 |
|
|
2022
Q3 | $703K | Sell |
8,866
-274
| -3% | -$21.7K | 0.08% | 112 |
|
|
2022
Q2 | $679K | Sell |
9,140
-678
| -7% | -$50.4K | 0.07% | 116 |
|
|
2022
Q1 | $882K | Buy |
9,818
+298
| +3% | +$26.8K | 0.08% | 86 |
|
|
2021
Q4 | $1.07M | Sell |
9,520
-726
| -7% | -$81.3K | 0.11% | 74 |
|
|
2021
Q3 | $1.29M | Sell |
10,246
-1,876
| -15% | -$236K | 0.14% | 67 |
|
|
2021
Q2 | $1.52M | Buy |
12,122
+3,893
| +47% | +$487K | 0.17% | 63 |
|
|
2021
Q1 | $1.12M | Buy |
8,229
+4,220
| +105% | +$572K | 0.16% | 61 |
|
|
2020
Q4 | $594K | Buy |
+4,009
| New | +$594K | 0.09% | 77 |
|